(Article) postMONARCH: A phase 3 study of abemaciclib plus fulvestrant versus placebo plus fulvestrant in patients with HR+, HER2-, metastatic breast cancer following progression on a CDK4 & 6 inhibitor and endocrine therapy.
by /u/animusrexalpha1 in /r/Scholar
Upvotes: 1
Favorite this post:
Mark as read:
Your rating:
Add this post to a custom list